A 2022 study (Frid et al., Mayo Clinic Proceedings , on subcutaneous injection technique) found that needle length is more often wrong on the long side than the short side
Putting the Results in Context The improvement seen in the active group (2650% on the investigator scale) over 6 months is encouraging, but context is essential: The improvement level is broadly comparable to other copper peptide studies, though direct comparison is difficult because this study used a categorical improvement scale rather than exact hair counts
Doctors can usually prescribe different medications within the same class, like GLP-1 receptor agonists, based on clinical judgment, although [this] varies due to factors like insurance requirements, formulary restrictions, medical history, and treatment goals, said Yoshua Quinones, MD, an internist with Medical Offices of Manhattan and contributor to LabFinder
See the "Important Safety Information" links below for more details